We analyzed responses to inhibitors of ERBB family receptor tyrosine kinases (RTKs) that have been previously shown to drive tumor progression in the KL GEMM, and found that only pan-ERBB inhibition increased the survival of ASCi.v. mice compared to control or single ERBB1/EGFR inhibition. Here, EGFR is linked to neoplasm.